Clinical Trial

Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy Volunteers

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A randomized, open-label, multiple-dose, crossover phase 1 clinical trial to compare and evaluate the safety, pharmacokinetics and pharmacodynamics characteristics after oral administration of UI059 and UIC202201 in healthy adult volunteers
Trial Details
NCT Number NCT07727629
Lead Sponsor Korea United Pharm. Inc.
Conditions Gastro Esophageal Reflux Disorder
Enrollment 60 participants
Start Date 2026-07
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-27